# A Study on the Safety, Tolerability and Pharmacokinetics of WS-0101 Tablets in Chinese Healthy Subjects

> **NCT06857799** · PHASE1 · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 27 (actual)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **PROCEDURE:** Light Power Density and Light Duration 40 mW/cm²*1000s
- **PROCEDURE:** Light Power Density and Light Duration 80 mW/cm²*1000s

## Key facts

- **NCT ID:** NCT06857799
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-13
- **Primary completion:** 2024-06-28
- **Final completion:** 2024-09-23
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06857799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06857799, "A Study on the Safety, Tolerability and Pharmacokinetics of WS-0101 Tablets in Chinese Healthy Subjects". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06857799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*